News round-up by DDW’s Reece Armstrong for 27 – 30 June.
Assays for monkeypox, Covid-19 boosters and approvals for oncology drugs are some of the themes of this week’s news round-up.
GSK & Sanofi first to report positive data for Omicron booster
GSK and Sanofi have reported positive efficacy data from a co-developed vaccine targeting the Omicron variant of Covid-19. The report makes GSK and Sanofi the first companies to have a vaccine candidate for the Omicron variant which has demonstrated efficacy.
UK’s NICE recommends Eli Lilly’s breast cancer drug
Early breast cancer patients in England will be able to access a new form of treatment following the recommendation for Eli Lilly’s abemaciclib by the National Institute of Health and Care Excellence (NICE).
US launches trial for potential universal flu vaccine
The National Institutes of Health (NIH) has launched a Phase I clinical trial for a potential universal flu vaccine.
Project granted £4.25m to advance research in motor neurone disease
Six UK universities have collectively received £4.25 million as part of a collaborative project aimed at finding new treatments for motor neurone disease (MND).
Novacyt launches monkeypox assay in response to outbreak
Clinical diagnostics company Novacyt has launched a polymerase chain reaction (PCR) monkeypox assay in response to the recent outbreak of the virus non-endemic countries.
